Your browser doesn't support javascript.
loading
Characteristics of Patients With Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences.
Guh, Alice Y; Li, Rongxia; Korhonen, Lauren; Winston, Lisa G; Parker, Erin; Czaja, Christopher A; Johnston, Helen; Basiliere, Elizabeth; Meek, James; Olson, Danyel; Fridkin, Scott K; Wilson, Lucy E; Perlmutter, Rebecca; Holzbauer, Stacy M; D'Heilly, Paige; Phipps, Erin C; Flores, Kristina G; Dumyati, Ghinwa K; Pierce, Rebecca; Ocampo, Valerie L S; Wilson, Christopher D; Watkins, Jasmine J; Gerding, Dale N; McDonald, L Clifford.
Afiliación
  • Guh AY; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Li R; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Korhonen L; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Winston LG; School of Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Parker E; California Emerging Infections Program, Oakland, California, USA.
  • Czaja CA; Colorado Department of Public Health and Environment, Denver,Colorado, USA.
  • Johnston H; Colorado Department of Public Health and Environment, Denver,Colorado, USA.
  • Basiliere E; Colorado Department of Public Health and Environment, Denver,Colorado, USA.
  • Meek J; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA.
  • Olson D; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA.
  • Fridkin SK; Emory University School of Medicine, Atlanta, Georgia, USA.
  • Wilson LE; University of Maryland Baltimore County, Baltimore, Maryland, USA.
  • Perlmutter R; Maryland Department of Health, Baltimore, Maryland, USA.
  • Holzbauer SM; Minnesota Department of Health, St Paul, Minnesota, USA.
  • D'Heilly P; Career Epidemiology Field Officer Program, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Phipps EC; Minnesota Department of Health, St Paul, Minnesota, USA.
  • Flores KG; New Mexico Emerging Infections Program, University of New Mexico, Albuquerque, New Mexico, USA.
  • Dumyati GK; New Mexico Emerging Infections Program, University of New Mexico, Albuquerque, New Mexico, USA.
  • Pierce R; New York Emerging Infections Program and University of Rochester Medical Center, Rochester, New York, USA.
  • Ocampo VLS; Oregon Health Authority, Portland, Oregon, USA.
  • Wilson CD; Oregon Health Authority, Portland, Oregon, USA.
  • Watkins JJ; Tennessee Department of Health, Nashville, Tennessee, USA.
  • Gerding DN; Tennessee Department of Health, Nashville, Tennessee, USA.
  • McDonald LC; Edward Hines, Jr. Veterans Affairs Hospital, Hines, Illinois, USA.
Open Forum Infect Dis ; 11(4): ofae127, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38577028
ABSTRACT

Background:

Because interventions are available to prevent further recurrence in patients with recurrent Clostridioides difficile infection (rCDI), we identified predictors of multiple rCDI (mrCDI) in adults at the time of presentation with initial CDI (iCDI).

Methods:

iCDI was defined as a positive C difficile test in any clinical setting during January 2018-August 2019 in a person aged ≥18 years with no known prior positive test. rCDI was defined as a positive test ≥14 days from the previous positive test within 180 days after iCDI; mrCDI was defined as ≥2 rCDI. We performed multivariable logistic regression analysis.

Results:

Of 18 829 patients with iCDI, 882 (4.7%) had mrCDI; 437 with mrCDI and 7484 without mrCDI had full chart reviews. A higher proportion of patients with mrCDI than without mrCDI were aged ≥65 years (57.2% vs 40.7%; P < .0001) and had healthcare (59.1% vs 46.9%; P < .0001) and antibiotic (77.3% vs 67.3%; P < .0001) exposures in the 12 weeks preceding iCDI. In multivariable analysis, age ≥65 years (adjusted odds ratio [aOR], 1.91; 95% confidence interval [CI], 1.55-2.35), chronic hemodialysis (aOR, 2.28; 95% CI, 1.48-3.51), hospitalization (aOR, 1.64; 95% CI, 1.33-2.01), and nitrofurantoin use (aOR, 1.95; 95% CI, 1.18-3.23) in the 12 weeks preceding iCDI were associated with mrCDI.

Conclusions:

Patients with iCDI who are older, on hemodialysis, or had recent hospitalization or nitrofurantoin use had increased risk of mrCDI and may benefit from early use of adjunctive therapy to prevent mrCDI. If confirmed, these findings could aid in clinical decision making and interventional study designs.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Open Forum Infect Dis Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
...